Authors: Chesnoy-Marchais, D Cathala, L

Citation: D. Chesnoy-marchais et L. Cathala, Modulation of glycine responses by dihydropyridines and verapamil in rat spinal neurons, EUR J NEURO, 13(12), 2001, pp. 2195-2204

Authors: de Beauregard, MAC Edelman, A Chesnoy-Marchais, D Tondelier, D Lapillonne, A El Marjou, F Robine, S Louvard, D

Citation: Mac. De Beauregard et al., Functional cystic fibrosis transmembrane conductance regulator tagged withan epitope of the vesicular stomatis virus glycoprotein can be addressed to the apical domain of polarized cells, EUR J CELL, 79(11), 2000, pp. 795-802

Authors: Supplisson, S Chesnoy-Marchais, D

Citation: S. Supplisson et D. Chesnoy-marchais, Glycine receptor beta subunits play a critical role in potentiation of glycine responses by ICS-205,930, MOLEC PHARM, 58(4), 2000, pp. 763-770

Authors: Chesnoy-Marchais, D Levi, S Acher, F

Citation: D. Chesnoy-marchais et al., Glycinergic potentiation by some 5-HT3 receptor antagonists: insight into selectivity, EUR J PHARM, 402(3), 2000, pp. 205-213

Authors: Levi, S Chesnoy-Marchais, D Sieghart, W Triller, A

Citation: S. Levi et al., Synaptic control of glycine and GABA(A) receptors and gephyrin expression in cultured motoneurons, J NEUROSC, 19(17), 1999, pp. 7434-7449

Authors: Chesnoy-Marchais, D

Citation: D. Chesnoy-marchais, Mode of action of ICS 205,930, a novel type of potentiator of responses toglycine in rat spinal neurones, BR J PHARM, 126(3), 1999, pp. 801-809